Vitality Biopharma Inc(OTCMKTS:VBIO) continues to trend higher in recent months since trading as low as $1.25 back in October of last year. Currently at the $2 mark VBIO has spiked as high as $2.75 in recent months and is looking to move towards previous highs.
VBIO operates in the red hot Marijuana industry that has quickly turned into a multi-billion dollar massive growth market that is sweeping across the Country with many new states legalizing the drug.
Vitality Biopharma Inc(OTCMKTS:VBIO) says it is dedicated to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. VBIO product pipeline includes Cannabosides – VITA-100 for gastrointestinal disorders, including inflammatory bowel disease and irritable bowel syndrome; Cannabosides – VITA-210 for muscle spasticity in multiple sclerosis and rare white matter disorders; and Cannabosides for epilepsy, schizophrenia, substance abuse, and Huntington’s disease.
Vitality Biopharma has developed a new class of cannabinoid prodrug, known as